Shareholders in heat-treatment group Bodycote (LSE:BOY) will vote on 21 October on a board-backed 940p-a-share cash offer from Veritas Capital, after a months-long bidding contest that drew in three buyout firms.
Bodycote, the world's largest provider of heat-treatment and specialist thermal processing services, is approaching the final stages of its life as a listed company. Shareholders will gather for a court meeting at 10am on 21 October, followed by a general meeting, to decide whether to approve a takeover by US buyout firm Veritas Capital. The proxy deadline falls on 19 October. If approved and sanctioned by the court, the deal is expected to become effective in the first quarter of 2027, after which the shares would be removed from the London Stock Exchange and the FTSE 250.
How the bidding contest unfolded
The sale process began in May, when the company confirmed on 22 May that it had received an unsolicited approach from Apollo. Apollo later walked away, and by August both CVC and Veritas had tabled near-identical proposals. Veritas raised its offer on 31 August, and on 1 September Bodycote's board announced that it would back a cash bid worth 940p per share. That figure comprises 932.8p in cash plus the 7.2p interim dividend declared with the half-year results. CVC's final enhanced proposal had been pitched at 915p including the dividend.
The terms value Bodycote's shares at about £1.65bn on a fully diluted basis, and the business at roughly £1.85bn including debt. The offer represents a premium of around 45% to the 647.8p closing price on 7 July, the last trading day before Veritas's initial proposal, and around 37.5% to the three-month volume-weighted average price to 21 May. The board unanimously described the terms as fair and reasonable, citing the certainty of cash against a difficult macroeconomic backdrop, weakness in automotive and general industrial markets, and the execution risk attached to its own strategy to 2028.
The contest effectively ended on 28 September, when CVC said it did not intend to make an offer. Bodycote published its scheme document the same day, setting out the voting arrangements. The scheme requires approval from a majority in number of shareholders voting at the court meeting, representing at least 75% by value, as well as a special resolution at the general meeting. Competition and regulatory clearances are also needed.
The business Veritas is buying
The bid follows a solid first half. Interim results published on 28 July showed revenue of £381.2m, up 3.3% on a reported basis and 6.5% organically, while adjusted operating profit rose 10.7% to £61.0m, lifting the margin to 16.0%. Adjusted earnings per share climbed 18.3% to 25.2p. Growth was led by Specialist Technologies, where organic revenue rose 16.7% and the margin reached 26.1%, with aerospace and defence now accounting for half of that division's sales. The company has also been shrinking its non-core portfolio under its Optimise programme.
The board had been returning cash through an £80m share buyback, buying shares at an average of roughly 680p during the first half, well below the eventual offer price. Net debt excluding leases stood at £135.2m at the end of June.
A familiar pattern in UK mid-caps
Bodycote (LSE:BOY) is the latest in a long line of London-listed industrial companies to attract overseas buyout interest, as buyers seek to exploit valuations that have lagged international peers. For the FTSE 250, the deal would mean the departure of another established engineering name. Attention now turns to the outcome of the votes and the regulatory timetable.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...